New trial aims to reduce urinary side effects in prostate cancer treatment
Symptom relief
Not yet recruiting
This study tests whether targeting only the visible tumor in the prostate (focal brachytherapy) causes fewer urinary problems than treating the whole gland. About 58 men with intermediate- or high-risk prostate cancer will receive either focal or standard whole gland brachytherap…
Phase: PHASE2 • Sponsor: Joelle Helou • Aim: Symptom relief
Last updated May 17, 2026 02:03 UTC